<DOC>
	<DOCNO>NCT03062033</DOCNO>
	<brief_summary>Prospective study quantify prevalence possible tardive dyskinesia ( TD ) outpatient psychiatry practice United States ( US ) , well describe associate disease burden cohort patient one psychiatric disorder cumulative lifetime exposure antipsychotic medication three month .</brief_summary>
	<brief_title>Real‐World Evaluation Screening Study Registry Dyskinesia Patients Taking Antipsychotic Agents</brief_title>
	<detailed_description />
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Patient cumulative lifetime exposure antipsychotic medication three month Patient clinician confirm diagnosis one psychiatric disorder ( ) , define DSM‐5 Patient usual care clinic visit schedule study recruitment window ( i.e . pre‐defined 2‐week period ) Patient able read understand English Patient willing able comply study requirement Patient unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>